BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38387831)

  • 1. Pathologic Assessment and Staging of Multiple Non-Small Cell Lung Carcinomas: A Paradigm Shift with the Emerging Role of Molecular Methods.
    Chang JC; Rekhtman N
    Mod Pathol; 2024 May; 37(5):100453. PubMed ID: 38387831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are there imaging characteristics that can distinguish separate primary lung carcinomas from intrapulmonary metastases using next-generation sequencing as a gold standard?
    Araujo-Filho JAB; Chang J; Mayoral M; Plodkowski AJ; Perez-Johnston R; Lobaugh S; Zheng J; Rusch VW; Rekhtman N; Ginsberg MS
    Lung Cancer; 2021 Mar; 153():158-164. PubMed ID: 33529990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Next-Generation Sequencing Unambiguously Distinguishes Separate Primary Lung Carcinomas From Intrapulmonary Metastases: Comparison with Standard Histopathologic Approach.
    Chang JC; Alex D; Bott M; Tan KS; Seshan V; Golden A; Sauter JL; Buonocore DJ; Vanderbilt CM; Gupta S; Desmeules P; Bodd FM; Riely GJ; Rusch VW; Jones DR; Arcila ME; Travis WD; Ladanyi M; Rekhtman N
    Clin Cancer Res; 2019 Dec; 25(23):7113-7125. PubMed ID: 31471310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic Profiling With Large-Scale Next-Generation Sequencing Panels Distinguishes Separate Primary Lung Adenocarcinomas From Intrapulmonary Metastases.
    Yang CY; Yeh YC; Wang LC; Lin YY; Lin SY; Wang SY; Chu PY; Liu ZY; Su YC; Ho HL; Chou TY
    Mod Pathol; 2023 Mar; 36(3):100047. PubMed ID: 36788096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic Staging of Multifocal Lung Squamous Cell Carcinomas Is Independent of the Comprehensive Morphologic Assessment.
    Dacic S; Cao X; Bota-Rabassedas N; Sanchez-Espiridion B; Berezowska S; Han Y; Chung JH; Beasley MB; Dongmei L; Hwang D; Mino-Kenudson M; Minami Y; Papotti M; Rekhtman N; Roden AC; Thunnissen E; Tsao MS; Yatabe Y; Yoshida A; Wang L; Hartman DJ; Jerome JA; Kadara H; Chou TY; Wistuba II;
    J Thorac Oncol; 2024 Feb; 19(2):273-284. PubMed ID: 37717856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Clinical Use of Genomic Profiling to Distinguish Intrapulmonary Metastases From Synchronous Primaries in Non-Small-Cell Lung Cancer: A Mini-Review.
    Klempner SJ; Ou SH; Costa DB; VanderLaan PA; Sanford EM; Schrock A; Gay L; Ali SM; Miller VA
    Clin Lung Cancer; 2015 Sep; 16(5):334-339.e1. PubMed ID: 25911330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interobserver Variation among Pathologists and Refinement of Criteria in Distinguishing Separate Primary Tumors from Intrapulmonary Metastases in Lung.
    Nicholson AG; Torkko K; Viola P; Duhig E; Geisinger K; Borczuk AC; Hiroshima K; Tsao MS; Warth A; Lantuejoul S; Russell PA; Thunnissen E; Marchevsky A; Mino-Kenudson M; Beasley MB; Botling J; Dacic S; Yatabe Y; Noguchi M; Travis WD; Kerr K; Hirsch FR; Chirieac LR; Wistuba II; Moreira A; Chung JH; Chou TY; Bubendorf L; Chen G; Pelosi G; Poleri C; Detterbeck FC; Franklin WA
    J Thorac Oncol; 2018 Feb; 13(2):205-217. PubMed ID: 29127023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive Mucinous Adenocarcinomas With Spatially Separate Lung Lesions: Analysis of Clonal Relationship by Comparative Molecular Profiling.
    Yang SR; Chang JC; Leduc C; Tan KS; Dogan S; Benayed R; Borsu L; Offin M; Drilon A; Travis WD; Arcila ME; Ladanyi M; Rekhtman N
    J Thorac Oncol; 2021 Jul; 16(7):1188-1199. PubMed ID: 33839364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel NGS-based diagnostic algorithm for classifying multifocal lung adenocarcinomas in pN0M0 patients.
    Zhang X; Fan X; Sun C; Wang L; Miao Y; Wang L; Yang P; Xu Y; Ren X; Wu X; Xu S
    J Pathol Clin Res; 2023 Mar; 9(2):108-120. PubMed ID: 36579550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive histologic assessment helps to differentiate multiple lung primary nonsmall cell carcinomas from metastases.
    Girard N; Deshpande C; Lau C; Finley D; Rusch V; Pao W; Travis WD
    Am J Surg Pathol; 2009 Dec; 33(12):1752-64. PubMed ID: 19773638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular profiling of key driver genes improves staging accuracy in multifocal non-small cell lung cancer.
    Zheng R; Shen Q; Mardekian S; Solomides C; Wang ZX; Evans NR
    J Thorac Cardiovasc Surg; 2020 Aug; 160(2):e71-e79. PubMed ID: 32007245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological and molecular approach to synchronous non-small cell lung carcinomas: impact on staging.
    Schneider F; Derrick V; Davison JM; Strollo D; Incharoen P; Dacic S
    Mod Pathol; 2016 Jul; 29(7):735-42. PubMed ID: 27080983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer.
    Wen S; Dai L; Wang L; Wang W; Wu D; Wang K; He Z; Wang A; Chen H; Zhang P; Dong X; Dong YA; Wang K; Yao M; Wang M
    Oncologist; 2019 Nov; 24(11):e1070-e1081. PubMed ID: 30902917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathologic and molecular approach to staging of multiple lung nodules.
    Schneider F; Dacic S
    Transl Lung Cancer Res; 2017 Oct; 6(5):540-549. PubMed ID: 29114470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using molecular characteristics to distinguish multiple primary lung cancers and intrapulmonary metastases.
    Li Z; Lv H; Zhang F; Zhu Z; Guo Q; Wang M; Huang C; Guo L; Meng F; Tian Z
    PeerJ; 2024; 12():e16808. PubMed ID: 38313018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy.
    Warth A; Macher-Goeppinger S; Muley T; Thomas M; Hoffmann H; Schnabel PA; Penzel R; Schirmacher P; Aulmann S
    Eur Respir J; 2012 Jun; 39(6):1437-42. PubMed ID: 22075483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive molecular analysis of driver mutations in non-small cell lung carcinomas and its correlation with PD-L1 expression, An Indian perspective.
    Aggarwal A; Sharma S; Brar Z; Kumar V; Kumar A; Katara R; Mohanty SK
    Pathol Res Pract; 2024 Jan; 253():155013. PubMed ID: 38096714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted deep sequencing helps distinguish independent primary tumors from intrapulmonary metastasis for lung cancer diagnosis.
    Liu J; Mao G; Li Y; Tao L; Wang W; Peng X; Wang J; Li X; Luan X; Luo R; Huang T; Zhang J; Xu M; Chen S; Wu D
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2359-2367. PubMed ID: 32333141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of genomic profiles between tissue-based and plasma-based next-generation sequencing in patients with non-small cell lung cancer.
    Lin Z; Li Y; Tang S; Deng Q; Jiang J; Zhou C
    Lung Cancer; 2023 Aug; 182():107282. PubMed ID: 37392713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Profiling of Multiple Primary Merkel Cell Carcinoma to Distinguish Genetically Distinct Tumors From Clonally Related Metastases.
    Harms KL; Lazo de la Vega L; Hovelson DH; Rahrig S; Cani AK; Liu CJ; Fullen DR; Wang M; Andea AA; Bichakjian CK; Johnson TM; Tomlins SA; Harms PW
    JAMA Dermatol; 2017 Jun; 153(6):505-512. PubMed ID: 28403382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.